A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. [electronic resource]

By:

Logothetis, L

Contributor(s):

Mylonas, I A
Baloyannis, S
Pashalidou, M
Orologas, A
Zafeiropoulos, A
Kosta, V
Theoharides, T C

Producer: 20060307Description: 771-8 p. digitalISSN:

0394-6320

Subject(s):

Adolescent
Adult
Caffeine -- therapeutic use
Central Nervous System Stimulants -- therapeutic use
Disability Evaluation
Female
Histamine H1 Antagonists -- adverse effects
Humans
Hydroxyzine -- adverse effects
Male
Multiple Sclerosis -- drug therapy
Multiple Sclerosis, Chronic Progressive -- drug therapy
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Pilot Projects
Upper Extremity -- physiology
Walking -- physiology

Online resources:

Available from publisher's website

In: International journal of immunopathology and pharmacology vol. 18

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Browse results Close

Back to results

41 The occurrence and significance of triploidy in the liver fluke, Fasciola hepatica.
by Fletcher, H L
42 cDNA cloning of the nucleocapsid and nucleocapsid-associated protein genes of mumps virus.
by Curran, J A
43 The complete nucleotide sequence of a bovine enterovirus.
by Earle, J A
44 Transcatheter coil embolisation: a novel definitive treatment option for intralobar pulmonary sequestration.
by Ganeshan, A
45 Atrial septal defects: magnetic resonance and computed tomography appearances.
by Hoey, E T D
46 The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy.
by Hoey, E T D
47 B-loop analogues of human epidermal growth factor; design, expression and properties.
by Taggart, C
48 Pain management in spinal metastases: the role of percutaneous vertebral augmentation.
by Kassamali, R H
49 Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
by Devine, C
50 Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
by Devine, C
51 Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
by Devine, C
52 Characterization of viral DNAs from cells infected with chicken anaemia agent: sequence analysis of the cloned replicative form and transfection capabilities of cloned genome fragments.
by Meehan, B M
53 Erratum to: inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
by Devine, C
54 Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
by Devine, C
55 Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole.
by Devine, C
56 Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
by Devine, C
57 Microtubules as antiparasitic drug targets.
by Fennell, Bj
58 Population dynamics of the liver fluke, Fasciola hepatica: the effect of time and spatial separation on the genetic diversity of fluke populations in the Netherlands.
by Walker, S M
59 Congenital and acquired conditions of the aortic root: multidetector computed tomography features.
by Vargas, H A
60 Substantial genetic divergence between morphologically indistinguishable populations of Fasciola suggests the possibility of cryptic speciation.
by Walker, S M

A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis.

APA

Logothetis L., Mylonas I. A., Baloyannis S., Pashalidou M., Orologas A., Zafeiropoulos A., Kosta V. & Theoharides T. C. (20060307). A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. : International journal of immunopathology and pharmacology.

Chicago

Logothetis L, Mylonas I A, Baloyannis S, Pashalidou M, Orologas A, Zafeiropoulos A, Kosta V and Theoharides T C. 20060307. A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. : International journal of immunopathology and pharmacology.

Harvard

Logothetis L., Mylonas I. A., Baloyannis S., Pashalidou M., Orologas A., Zafeiropoulos A., Kosta V. and Theoharides T. C. (20060307). A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. : International journal of immunopathology and pharmacology.

MLA

Logothetis L, Mylonas I A, Baloyannis S, Pashalidou M, Orologas A, Zafeiropoulos A, Kosta V and Theoharides T C. A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. : International journal of immunopathology and pharmacology. 20060307.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC